Mileski, William J <br/><br/>
Clinical effects of inhibiting leukocyte adhesion with monoclonal antibody to intercellular adhesion molecule-1 (enlimomab) in the treatment of partial-thickness burn injury.  [electronic resource] 

 -  The Journal of trauma  May 2003 
 - 950-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0022-5282 
<br/><br/><label>Standard No.: </label>10.1097/01.TA.0000030626.84680.11  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Murine-Derived<br/>Burns--blood<br/>Female<br/>Humans<br/>Intercellular Adhesion Molecule-1--immunology<br/>Male<br/>Receptors, Leukocyte-Adhesion--antagonists & inhibitors<br/>Regression Analysis